Last10K.com

Adynxx, Inc. (ADYX) SEC Filing 8-K Material Event for the period ending Tuesday, July 16, 2019

Alliqua Biomedical, Inc.

HISTORY TOOLS
CIK: 842717 Ticker: ADYX

View differences made from one to another to evaluate Alliqua Biomedical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alliqua Biomedical, Inc..

Continue

Assess how Alliqua Biomedical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alliqua Biomedical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ADYX
CIK: 1054274
Form Type: 8-K Corporate News
Accession Number: 0001437749-19-014312
Submitted to the SEC: Mon Jul 22 2019 6:30:44 AM EST
Accepted by the SEC: Mon Jul 22 2019
Period: Tuesday, July 16, 2019
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/adyx/0001437749-19-014312.htm